Deutsche Bank’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Sell |
147,525
-228,535
| -61% | -$3M | ﹤0.01% | 1720 |
|
|
2025
Q1 | $8.27M | Buy |
376,060
+100,223
| +36% | +$2.2M | ﹤0.01% | 1054 |
|
|
2024
Q4 | $7.36M | Buy |
275,837
+57,955
| +27% | +$1.55M | ﹤0.01% | 1143 |
|
|
2024
Q3 | $5.82M | Buy |
217,882
+186,768
| +600% | +$4.98M | ﹤0.01% | 1211 |
|
|
2024
Q2 | $560K | Buy |
31,114
+5,840
| +23% | +$105K | ﹤0.01% | 2248 |
|
|
2024
Q1 | $461K | Buy |
25,274
+4,864
| +24% | +$88.7K | ﹤0.01% | 2360 |
|
|
2023
Q4 | $223K | Sell |
20,410
-687
| -3% | -$7.52K | ﹤0.01% | 2767 |
|
|
2023
Q3 | $121K | Buy |
21,097
+3,177
| +18% | +$18.2K | ﹤0.01% | 3042 |
|
|
2023
Q2 | $139K | Sell |
17,920
-5,677
| -24% | -$44K | ﹤0.01% | 3086 |
|
|
2023
Q1 | $157K | Buy |
23,597
+6,960
| +42% | +$46.4K | ﹤0.01% | 3110 |
|
|
2022
Q4 | $149K | Buy |
16,637
+4,573
| +38% | +$40.9K | ﹤0.01% | 3108 |
|
|
2022
Q3 | $119K | Sell |
12,064
-1,991
| -14% | -$19.6K | ﹤0.01% | 3209 |
|
|
2022
Q2 | $112K | Sell |
14,055
-7,941
| -36% | -$63.3K | ﹤0.01% | 3449 |
|
|
2022
Q1 | $214K | Sell |
21,996
-2,498
| -10% | -$24.3K | ﹤0.01% | 3206 |
|
|
2021
Q4 | $374K | Buy |
24,494
+17,124
| +232% | +$261K | ﹤0.01% | 2991 |
|
|
2021
Q3 | $122K | Buy |
7,370
+25
| +0.3% | +$414 | ﹤0.01% | 3760 |
|
|
2021
Q2 | $156K | Buy |
+7,345
| New | +$156K | ﹤0.01% | 3870 |
|